These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. Glesby MJ; Hoover DR; Weng S; Graham NM; Phair JP; Detels R; Ho M; Saah AJ J Infect Dis; 1996 Jun; 173(6):1477-80. PubMed ID: 8648224 [TBL] [Abstract][Full Text] [Related]
3. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626 [TBL] [Abstract][Full Text] [Related]
7. Some antivirals may lower Kaposi's sarcoma risk. Larkin M Lancet; 1996 Sep; 348(9030):812. PubMed ID: 8813992 [No Abstract] [Full Text] [Related]
8. Kaposi's sarcoma. A finger on the culprit. Schulz TF; Weiss RA Nature; 1995 Jan; 373(6509):17-8. PubMed ID: 7800029 [No Abstract] [Full Text] [Related]
9. Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir. Conant MA; Opp KM; Poretz D; Mills RG AIDS; 1997 Aug; 11(10):1300-1. PubMed ID: 9256954 [No Abstract] [Full Text] [Related]
10. Herpesvirus treatment for KS. Treat Rev; 1995 Nov; (no 20):5. PubMed ID: 11363024 [TBL] [Abstract][Full Text] [Related]
11. Childhood infections with human herpesviruses types 6, 7, and 8. Grose C Adv Pediatr Infect Dis; 1996; 12():181-208. PubMed ID: 9033979 [No Abstract] [Full Text] [Related]
12. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine. Costagliola D; Mary-Krause M Lancet; 1995 Aug; 346(8974):578. PubMed ID: 7658802 [No Abstract] [Full Text] [Related]
13. Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Boivin G; Gaudreau A; Toma E; Lalonde R; Routy JP; Murray G; Handfield J; Bergeron MG Antimicrob Agents Chemother; 1999 Feb; 43(2):377-80. PubMed ID: 9925538 [TBL] [Abstract][Full Text] [Related]
14. Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome. Löw P; Neipel F; Rascu A; Steininger H; Manger B; Fleckenstein B; Kalden JR; Harrer T Eur J Med Res; 1998 Oct; 3(10):461-4. PubMed ID: 9753702 [TBL] [Abstract][Full Text] [Related]